NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Data Points Publication Series [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011-.
Figure 8Growth in the proportion of ESA-using beneficiaries without chronic kidney disease, but reporting intermittent kidney disease
- Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.[Vaccine. 2019]Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.Shen AK, Warnock R, Selna W, MaCurdy TE, Chu S, Kelman JA. Vaccine. 2019 Feb 21; 37(9):1194-1201. Epub 2019 Jan 22.
- Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease.[J Vasc Surg Venous Lymphat Dis...]Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease.Gloviczki P, Dalsing MC, Henke P, Lal BK, O'Donnell TF Jr, Shortell CK, Huang Y, Markovic J, Wakefield TW. J Vasc Surg Venous Lymphat Disord. 2017 May; 5(3):378-398.
- Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.[JACC Cardiovasc Imaging. 2019]Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.Herzog CA, Natwick T, Li S, Charytan DM. JACC Cardiovasc Imaging. 2019 Aug; 12(8 Pt 1):1420-1426. Epub 2018 Jun 13.
- Review Summary of the 2018 Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for transcatheter aortic valve replacement.[Cardiovasc Revasc Med. 2018]Review Summary of the 2018 Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for transcatheter aortic valve replacement.Rogers T, Khan JM, Edelman JJ, Waksman R. Cardiovasc Revasc Med. 2018 Dec; 19(8):964-970. Epub 2018 Oct 9.
- Review Medicare Part D-a roundtable discussion of current issues and trends.[J Manag Care Pharm. 2009]Review Medicare Part D-a roundtable discussion of current issues and trends.Balfour DC 3rd, Evans S, Januska J, Lee HY, Lewis SJ, Nolan SR, Noga M, Stemple C, Thapar K. J Manag Care Pharm. 2009 Jan-Feb; 15(1 Suppl A):3-9.
- Figure 8, Growth in the proportion of ESA-using beneficiaries without chronic ki...Figure 8, Growth in the proportion of ESA-using beneficiaries without chronic kidney disease, but reporting intermittent kidney disease - Data Points Publication Series
Your browsing activity is empty.
Activity recording is turned off.
See more...